Three-dimensional Elastic Augmented-reality Robot-assisted Radical Prostatectomy Using Hyperaccuracy Three-dimensional Reconstruction Technology: A Step Further in the Identification of Capsular Involvement.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
10 2019
Historique:
received: 28 12 2018
accepted: 26 03 2019
pubmed: 14 4 2019
medline: 5 1 2021
entrez: 14 4 2019
Statut: ppublish

Résumé

In prostate cancer (PCa) surgical procedures, in order to maximize potency recovery, a nerve-sparing (NS) procedure is preferred. However, cancer abutting or focally extending beyond the prostate capsule increases the risk of a positive surgical margin. To evaluate the accuracy of our new three-dimensional (3D) elastic augmented-reality (AR) system in identifying capsular involvement (CI) location of PCa during the NS phase of robot-assisted radical prostatectomy (RARP). Secondarily, the accuracy of this technology was compared with two-dimensional (2D)-based cognitive procedures. A prospective study, enrolling 40 patients with PCa undergoing RARP at our center, from May to October 2018. Patients underwent 3D AR RARP or, in case of unavailability of this technology, 2D cognitive RARP. In all patients, total anatomical reconstruction was used. Clinical data were collected. In order to compare the two groups, nonparametric Mann-Whitney and chi-square tests were performed. A metallic clip was placed at the level of suspicious CI on the basis of images given by the 3D AR or magnetic resonance imaging (MRI) report. The pathological analysis evaluated the presence of tumor at the level of the clip. Twenty patients were enrolled in each group. Focusing on the 3D AR group at macroscopic evaluation, the metallic clip was placed at the tumor and capsular bulging in all cases. At microscopic assessment, cancer presence was confirmed in the suspicious area in 95.4% of the cases. Moreover, CI was correctly identified in 100.0% of the cases, thanks to the 3D image overlap. These results were compared with the 2D MRI cognitive group, showing, at microscopic analysis, statistically significant superiority of the 3D AR group in CI detection during the NS phase (100% vs 47.0%; p<0.05). The main limitation of this technique is that the segmentation and overlapping of the images are performed manually. Our findings suggest that, with the introduction of the elastic 3D virtual models, prostate deformation is correctly simulated during surgery and lesion location is correctly identified, even in dynamic reality with a subsequent potential reduction of positive surgical margin rate and, in the meantime, maximization of functional outcomes. On the basis of our findings, the three-dimensional elastic augmented-reality technology seems to help the surgeon in lesion location identification even in a dynamic phase of the intervention, optimizing the oncological outcomes.

Sections du résumé

BACKGROUND
In prostate cancer (PCa) surgical procedures, in order to maximize potency recovery, a nerve-sparing (NS) procedure is preferred. However, cancer abutting or focally extending beyond the prostate capsule increases the risk of a positive surgical margin.
OBJECTIVE
To evaluate the accuracy of our new three-dimensional (3D) elastic augmented-reality (AR) system in identifying capsular involvement (CI) location of PCa during the NS phase of robot-assisted radical prostatectomy (RARP). Secondarily, the accuracy of this technology was compared with two-dimensional (2D)-based cognitive procedures.
DESIGN, SETTING, AND PARTICIPANTS
A prospective study, enrolling 40 patients with PCa undergoing RARP at our center, from May to October 2018.
SURGICAL PROCEDURE
Patients underwent 3D AR RARP or, in case of unavailability of this technology, 2D cognitive RARP. In all patients, total anatomical reconstruction was used.
MEASUREMENTS
Clinical data were collected. In order to compare the two groups, nonparametric Mann-Whitney and chi-square tests were performed. A metallic clip was placed at the level of suspicious CI on the basis of images given by the 3D AR or magnetic resonance imaging (MRI) report. The pathological analysis evaluated the presence of tumor at the level of the clip.
RESULTS AND LIMITATIONS
Twenty patients were enrolled in each group. Focusing on the 3D AR group at macroscopic evaluation, the metallic clip was placed at the tumor and capsular bulging in all cases. At microscopic assessment, cancer presence was confirmed in the suspicious area in 95.4% of the cases. Moreover, CI was correctly identified in 100.0% of the cases, thanks to the 3D image overlap. These results were compared with the 2D MRI cognitive group, showing, at microscopic analysis, statistically significant superiority of the 3D AR group in CI detection during the NS phase (100% vs 47.0%; p<0.05). The main limitation of this technique is that the segmentation and overlapping of the images are performed manually.
CONCLUSIONS
Our findings suggest that, with the introduction of the elastic 3D virtual models, prostate deformation is correctly simulated during surgery and lesion location is correctly identified, even in dynamic reality with a subsequent potential reduction of positive surgical margin rate and, in the meantime, maximization of functional outcomes.
PATIENT SUMMARY
On the basis of our findings, the three-dimensional elastic augmented-reality technology seems to help the surgeon in lesion location identification even in a dynamic phase of the intervention, optimizing the oncological outcomes.

Identifiants

pubmed: 30979636
pii: S0302-2838(19)30270-2
doi: 10.1016/j.eururo.2019.03.037
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-514

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Francesco Porpiglia (F)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy. Electronic address: porpiglia@libero.it.

Enrico Checcucci (E)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Daniele Amparore (D)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Matteo Manfredi (M)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Federica Massa (F)

Department of Pathology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Pietro Piazzolla (P)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Diego Manfrin (D)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Alberto Piana (A)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Daniele Tota (D)

Department of Pathology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Enrico Bollito (E)

Department of Pathology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Cristian Fiori (C)

Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH